100 related articles for article (PubMed ID: 21778941)
1. Alteration in NFKBIA and EGFR in glioblastoma multiforme.
Komotar RJ; Starke RM; Connolly ES; Sisti MB
Neurosurgery; 2011 Jun; 68(6):N14-5. PubMed ID: 21778941
[No Abstract] [Full Text] [Related]
2. NFKBIA deletion in glioblastomas.
Idbaih A; Marie Y; Sanson M
N Engl J Med; 2011 Jul; 365(3):277; author reply 277-8. PubMed ID: 21774727
[No Abstract] [Full Text] [Related]
3. Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.
Patanè M; Porrati P; Bottega E; Morosini S; Cantini G; Girgenti V; Rizzo A; Eoli M; Pollo B; Sciacca FL; Pellegatta S; Finocchiaro G
Mol Cancer; 2013 Dec; 12():160. PubMed ID: 24330732
[TBL] [Abstract][Full Text] [Related]
4. NFKBIA deletion in glioblastomas.
Bredel M; Scholtens DM; Yadav AK; Alvarez AA; Renfrow JJ; Chandler JP; Yu IL; Carro MS; Dai F; Tagge MJ; Ferrarese R; Bredel C; Phillips HS; Lukac PJ; Robe PA; Weyerbrock A; Vogel H; Dubner S; Mobley B; He X; Scheck AC; Sikic BI; Aldape KD; Chakravarti A; Harsh GR
N Engl J Med; 2011 Feb; 364(7):627-37. PubMed ID: 21175304
[TBL] [Abstract][Full Text] [Related]
5. NFKBIA deletion in glioblastomas.
Takeuchi S; Nawashiro H
N Engl J Med; 2011 Jul; 365(3):276-7; author reply 277-8. PubMed ID: 21774728
[No Abstract] [Full Text] [Related]
6. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
Benito R; Gil-Benso R; Quilis V; Perez M; Gregori-Romero M; Roldan P; Gonzalez-Darder J; Cerdá-Nicolas M; Lopez-Gines C
Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
[TBL] [Abstract][Full Text] [Related]
7. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
[TBL] [Abstract][Full Text] [Related]
8. Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.
Zhao Z; Zhong X; Wu T; Yang T; Chen G; Xie X; Wei Y; Ye M; Zhou Y; Du Z
Int J Mol Med; 2014 Nov; 34(5):1233-40. PubMed ID: 25215581
[TBL] [Abstract][Full Text] [Related]
9. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.
von Deimling A; Louis DN; von Ammon K; Petersen I; Hoell T; Chung RY; Martuza RL; Schoenfeld DA; Yaşargil MG; Wiestler OD
J Neurosurg; 1992 Aug; 77(2):295-301. PubMed ID: 1320666
[TBL] [Abstract][Full Text] [Related]
10. Amplification and differential expression of members of the erbB-gene family in human glioblastoma.
Schlegel J; Stumm G; Brändle K; Merdes A; Mechtersheimer G; Hynes NE; Kiessling M
J Neurooncol; 1994; 22(3):201-7. PubMed ID: 7760096
[TBL] [Abstract][Full Text] [Related]
11. Primary glioblastoma with EGFR amplification and a ring chromosome 7 in a young patient.
Lopez-Gines C; Cerdá-Nicolás M; Gil-Benso R; Pellin A; López-Guerrero JA; Benito R; del Rey J; Miró R; Roldan R; Barberá J
Clin Neuropathol; 2006; 25(4):193-9. PubMed ID: 16866301
[TBL] [Abstract][Full Text] [Related]
12. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.
Giannini C; Sarkaria JN; Saito A; Uhm JH; Galanis E; Carlson BL; Schroeder MA; James CD
Neuro Oncol; 2005 Apr; 7(2):164-76. PubMed ID: 15831234
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.
Lu Z; Zhou L; Killela P; Rasheed AB; Di C; Poe WE; McLendon RE; Bigner DD; Nicchitta C; Yan H
Cancer Res; 2009 Dec; 69(23):9105-11. PubMed ID: 19920201
[TBL] [Abstract][Full Text] [Related]
14. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways in the formation of gliomas.
von Deimling A; Louis DN; Wiestler OD
Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467
[TBL] [Abstract][Full Text] [Related]
17. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
[TBL] [Abstract][Full Text] [Related]
18. Pathology: commonly monitored glioblastoma markers: EFGR, EGFRvIII, PTEN, and MGMT.
Camara-Quintana JQ; Nitta RT; Li G
Neurosurg Clin N Am; 2012 Apr; 23(2):237-46, viii. PubMed ID: 22440867
[TBL] [Abstract][Full Text] [Related]
19. MRI study identifies three subtypes of glioblastoma.
Brower V
Lancet Oncol; 2015 Oct; 16(13):e484. PubMed ID: 26365415
[No Abstract] [Full Text] [Related]
20. Epidermal growth factor receptor: a re-emerging target in glioblastoma.
Hegi ME; Rajakannu P; Weller M
Curr Opin Neurol; 2012 Dec; 25(6):774-9. PubMed ID: 23007009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
